Key Findings

The study identified AmpC hyperproduction as the primary mechanism of resistance to ceftazidime (CAZ) in Pseudomonas aeruginosa, both in vitro and in vivo. This resistance mechanism was observed in both wild-type and hypermutable strains, with increased beta-lactamase activity contributing to resistance against β-lactam antibiotics.